Here's what's been proven to help GLP-1 users from losing too much muscle from the drug
By Jaimy Lee
People taking Zepbound who engage in consistent resistance training can still get stronger even if they lose some of their muscle, according to a new study
A new study found that resistance training can offset the loss of lean muscle mass in people taking Zepbound - and even make them stronger.
Losing weight while taking a GLP-1 medication isn't just about the numbers on a scale.
New research says that healthy weight loss with a GLP-1 drug like Eli Lilly's (LLY) Zepbound or Novo Nordisk's (NVO) Wegovy is aided by resistance training, which can offset the decline of lean muscle mass common in anyone who is losing weight.
"Although they lose lean mass, [someone] can still maintain and, in this case, even improve their overall strength and the function of their muscular system," said Jacque Crockford, a health coach and director of product development at the American Council on Exercise. That's "a really good indicator of why exercise is so important in conjunction with any kind of weight-loss journey."
The study, which came out this month, is the first to evaluate the role of resistance training in people taking the most popular weight-loss drug on the market. It showed that people taking Zepbound who lifted weights still lost lean muscle mass, but not as much as people on the drug who were not lifting weights. The weightlifters increased their muscle strength while on Zepbound. In other words, they were able to get stronger even though they lost muscle mass.
The findings also reinforced the idea that lifting weights and eating a protein-packed diet can counter the loss of lean muscle, which is a major concern for anyone who has taken a GLP-1 drug, whether that's older adults, those who stopped treatment or longevity-focused individuals.
"Lifting + GLP-1s [for the win]" is how biohacker Bryan Johnson described the study on X, while Lilly CEO Dave Ricks said, "macros plus resistance is the way." (Macros is short for macronutrients, a term commonly used by people who track their intake of carbohydrates, proteins and fats.)
About 11% of adults in the U.S. are taking a GLP-1 medication for weight loss, according to a recent Gallup survey. One of the biggest concerns about those powerful medicines is muscle loss. Research has found that people taking these medications lose between 15% and 60% of their lean mass proportional to weight loss. At the same time, people naturally start losing about 1% of their muscle mass every year starting at age 35. By the time they turn 60, they can lose up to 3% of their muscle mass per year.
Taking a GLP-1 drug when you're older can accelerate that process, according to Jeffrey Egler, chief medical officer at Noom.
"Our older populations are at risk already of having too little lean muscle to support their daily activities," he said. "They get less activity in general. They're losing muscle mass. This is one of the main reasons that we see deterioration with aging."
Strength: More important than muscle mass?
The study's researchers randomized 120 adults between the ages of 50 and 70 into two groups. The trial subjects were overweight or obese and starting treatment with Zepbound. One group maintained normal activity, and the other did resistance training three times a week. That included using tools like bands or free weights or engaging in body-weight exercises like push-ups or squats.
The patients, who weren't instructed to make any dietary changes, were then assessed using a DEXA scan to estimate the differences in body composition after about 10 months.
Both groups lost similar amounts of weight and fat mass, reported smaller waists and a lower body-mass index, and saw comparable improvements in blood pressure, glycemia and lipids. However, the people who did resistance training lost less muscle mass, which helps boost metabolism, control blood sugar, and lower the risk of heart attacks or even death, than those only taking the medication. Notably, they gained upper- and lower-body muscle strength.
"Strength is a more important outcome than muscle mass because it relates to function and frailty," Danny Green, the study's lead researcher and director of the University of Western Australia's HealthSpan Institute, said in an email.
About 20 years ago, Green ran a resistance-training program in a pediatric hospital for overweight and obese children and teens. The kids loved it, he said, even though they didn't lose any weight. However, DEXA scans showed that the participants had lowered their fat mass and increased their lean muscle mass.
When the results for the clinical trials for Zepbound and Wegovy came out, he immediately wanted to understand how much of that weight loss was the loss of muscle.
"The optimal midlife intervention for people who want to prolong their healthspan would decrease fat mass - GLPs do this incredibly well - but it should also maintain their lean and muscle mass and, more importantly, their strength and function," Green added.
For those middle-aged or older, maintaining muscle strength is key to aging well. It can prevent someone from falling or developing joint issues later in life while also allowing them to stay active in their daily lives.
Not only can losing muscle mass raise the risk of frailty, but it's a big enough problem that several drugmakers are already working on new weight-loss therapies to prevent muscle loss from GLP-1 medications. That includes Lilly's bimagrumab, which is in Phase 2 trials. Other companies like Regeneron (REGN), Scholar Rock (SRRK) and Veru (VERU) are all working on add-on therapies to take alongside Zepbound or Wegovy.
For now, however, people who are taking GLP-1 drugs for weight loss should focus on healthy lifestyle choices like eating enough protein, reducing stress and getting good sleep, in addition to developing a resistance training plan that works for them and their schedule. In the study, 91% of the study's participants adhered to the resistance training program. In the real world, it can be challenging for patients to find time to work out regularly - even when they understand the benefits.
"What we say in the field of longevity is that muscle is longevity, strength is longevity, and any personal trainer - they are religious about this," Egler said. "If you lose a pound of muscle, they think that you've lost a pound of your vitality."
-Jaimy Lee
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
11-21-26 1003ET
Copyright (c) 2026 Dow Jones & Company, Inc.The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular

5 Stocks to Buy After Earnings

The 10 Best Dividend Stocks

2 5-Star Stocks to Buy at Big Discounts

The Best Balanced Funds and ETFs

